Hua Xing Capital Holdings: Weigao Blood successfully listed on the main board of the Shanghai Stock Exchange
I'm LongbridgeAI, I can summarize articles.
China Renaissance Holdings announced that its subsidiary, China Renaissance New Economy Fund, has successfully listed Shandong Weigao Blood Purification Products Co., Ltd. on the main board of the Shanghai Stock Exchange, with the stock code 603014. Weigao Blood Purification is a leading enterprise in China's blood purification industry, focusing on the research and development of hemodialysis and peritoneal dialysis. The China Renaissance New Economy Fund led the pre-IPO financing for Weigao Blood Purification in 2022, with a total investment amount of 450 million RMB, demonstrating recognition and confidence in its industry position
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments